---
title: "Imatinib - Dermatofibrosarcoma"
sidebar: mydoc_sidebar
permalink: db00619-mesh-d018223-1.html
toc: false 
---


Path ID: `DB00619_MESH_D018223_1`
{% include image.html url="images/db00619-mesh-d018223-1.png" file="db00619-mesh-d018223-1.png" alt="db00619-mesh-d018223-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000068877 | imatinib | Drug |
| MESH:D050506 | Mutant Chimeric Proteins | GeneFamily |
| MESH:D010982 | Platelet-Derived Growth Factor | GeneFamily |
| GO:0030154 | cell differentiation | BiologicalProcess |
| GO:0008283 | cell population proliferation | BiologicalProcess |
| MESH:D002470 | Cell Survival | BiologicalProcess |
| MESH:D018223 | Dermatofibrosarcoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Imatinib | DECREASES ACTIVITY OF | Mutant Chimeric Proteins |
| Mutant Chimeric Proteins | DERIVES FROM | Platelet-Derived Growth Factor |
| Platelet-Derived Growth Factor | POSITIVELY REGULATES | Cell Differentiation |
| Platelet-Derived Growth Factor | POSITIVELY REGULATES | Cell Population Proliferation |
| Platelet-Derived Growth Factor | POSITIVELY REGULATES | Cell Survival |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Dermatofibrosarcoma |
| Cell Survival | POSITIVELY CORRELATED WITH | Dermatofibrosarcoma |
| Cell Differentiation | POSITIVELY CORRELATED WITH | Dermatofibrosarcoma |
|---------|-----------|---------|

Reference: 
  - [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate)
  - [https://en.wikipedia.org/wiki/Dermatofibrosarcoma_protuberans#Pathophysiology](https://en.wikipedia.org/wiki/Dermatofibrosarcoma_protuberans#Pathophysiology)
  - [https://en.wikipedia.org/wiki/Imatinib#Dermatofibrosarcoma_protuberans_(DFSP)](https://en.wikipedia.org/wiki/Imatinib#Dermatofibrosarcoma_protuberans_(DFSP))
